Key facts
- · Type: Amendment first sale 2025-07-31 · Amount sold: $320.82M · Total offering: $320.82M · SEC filing
- · Type: New offering first sale 2025-07-31 · Amount sold: $313.30M · Total offering: $313.30M · SEC filing
- · Type: Amendment · SEC filing
Is Kriya Therapeutics, Inc. a real, registered company?
Kriya Therapeutics, Inc. is a registered filer with the SEC (CIK 1811209) and has filed since 2023-07-27. 3 filings are on record, the latest on 2025-09-10.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
How much has Kriya Therapeutics, Inc. raised?
Its new offerings report $313.30M sold across 1 offering, as its own filings state.
Run the free check on Kriya Therapeutics, Inc. →
MORRISVILLE, NORTH CAROLINA
Biotechnology
3
$313.30M
Every filing
| Filed | Type | Amount sold | Total offering | Records |
|---|---|---|---|---|
| 2025-09-10 | Amendment first sale 2025-07-31 | $320.82M | $320.82M | SEC filing |
| 2025-08-15 | New offering first sale 2025-07-31 | $313.30M | $313.30M | SEC filing |
| 2023-07-27 | Amendment | — | — | SEC filing |
Keep reading
More on Kriya Therapeutics, Inc. and the records around it.
Kriya Therapeutics, Inc. elsewhere on the record
- Form D filing Aug 2025
Watch Kriya Therapeutics, Inc.
Get an email when Kriya Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with Kriya Therapeutics, Inc.?
Who to contact
- Shankar Ramaswamy — Executive Officer, Director
- Trit Garg — Director
- Ryan Gallagher — Director
- Roger Jeffs — Director
- Keith Manchester — Director
- James Momtazee — Director
- Ilan Oren — Director
- Akshay Rai — Director
- Saira Ramasastry — Director
- Neelaksh Varshney — Director
- Curt Herberts — Executive Officer
- Katherine Eade — Executive Officer
- Brian Furmanski — Executive Officer
- Britt Petty — Executive Officer
- Michele Stone — Executive Officer
- Round: Form D/A (amended) filed 2025-09-10
- Amount sold: $320.82M
- Industry: Biotechnology
- Based: MORRISVILLE, NORTH CAROLINA
People listed
- Shankar Ramaswamy — Executive Officer, Director
- Trit Garg — Director
- Ryan Gallagher — Director
- Roger Jeffs — Director
- Keith Manchester — Director
- James Momtazee — Director
- Ilan Oren — Director
- Akshay Rai — Director
- Saira Ramasastry — Director
- Neelaksh Varshney — Director
- Curt Herberts — Executive Officer
- Katherine Eade — Executive Officer
- Brian Furmanski — Executive Officer
- Britt Petty — Executive Officer
- Michele Stone — Executive Officer
- Filing: Form D/A (amended) filed 2025-09-10
- Amount sold: $320.82M
- Industry group: Biotechnology
- Based: MORRISVILLE, NORTH CAROLINA
- Entity type: Corporation
We'll show it in your MentionFox inbox when Kriya Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Kriya Therapeutics, Inc. →Want the whole picture on Kriya Therapeutics, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Kriya Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Kriya Therapeutics, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
5 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.
Every figure here is read from Kriya Therapeutics, Inc.'s own filings with the SEC. The people those filings name are on the team page.